85 related articles for article (PubMed ID: 14648614)
41. Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2'-ligands.
Ghosh AK; Schiltz G; Perali RS; Leshchenko S; Kay S; Walters DE; Koh Y; Maeda K; Mitsuya H
Bioorg Med Chem Lett; 2006 Apr; 16(7):1869-73. PubMed ID: 16480871
[TBL] [Abstract][Full Text] [Related]
42. Computational proteomics analysis of binding mechanisms and molecular signatures of the HIV-1 protease drugs.
Verkhivker G
Artif Intell Med; 2009; 45(2-3):197-206. PubMed ID: 18926674
[TBL] [Abstract][Full Text] [Related]
43. Hydrophobicity in the design of P2/P2' tetrahydropyrimidinone HIV protease inhibitors.
Garg R; Patel D
Bioorg Med Chem Lett; 2005 Aug; 15(16):3767-70. PubMed ID: 15993582
[TBL] [Abstract][Full Text] [Related]
44. Small-sized human immunodeficiency virus type-1 protease inhibitors containing allophenylnorstatine to explore the S2' pocket.
Hidaka K; Kimura T; Abdel-Rahman HM; Nguyen JT; McDaniel KF; Kohlbrenner WE; Molla A; Adachi M; Tamada T; Kuroki R; Katsuki N; Tanaka Y; Matsumoto H; Wang J; Hayashi Y; Kempf DJ; Kiso Y
J Med Chem; 2009 Dec; 52(23):7604-17. PubMed ID: 19954246
[TBL] [Abstract][Full Text] [Related]
45. Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes.
Rezácová P; Pokorná J; Brynda J; Kozísek M; Cígler P; Lepsík M; Fanfrlík J; Rezác J; Grantz Sasková K; Sieglová I; Plesek J; Sícha V; Grüner B; Oberwinkler H; Sedlácek' J; Kräusslich HG; Hobza P; Král V; Konvalinka J
J Med Chem; 2009 Nov; 52(22):7132-41. PubMed ID: 19874035
[TBL] [Abstract][Full Text] [Related]
46. MUSTANG: a multiple structural alignment algorithm.
Konagurthu AS; Whisstock JC; Stuckey PJ; Lesk AM
Proteins; 2006 Aug; 64(3):559-74. PubMed ID: 16736488
[TBL] [Abstract][Full Text] [Related]
47. Discovery of potent pyrrolidone-based HIV-1 protease inhibitors with enhanced drug-like properties.
Kazmierski WM; Andrews W; Furfine E; Spaltenstein A; Wright L
Bioorg Med Chem Lett; 2004 Nov; 14(22):5689-92. PubMed ID: 15482949
[TBL] [Abstract][Full Text] [Related]
48. Detecting local structural similarity in proteins by maximizing number of equivalent residues.
Standley DM; Toh H; Nakamura H
Proteins; 2004 Nov; 57(2):381-91. PubMed ID: 15340925
[TBL] [Abstract][Full Text] [Related]
49. 3D-Epitope-Explorer (3DEX): localization of conformational epitopes within three-dimensional structures of proteins.
Schreiber A; Humbert M; Benz A; Dietrich U
J Comput Chem; 2005 Jul; 26(9):879-87. PubMed ID: 15834923
[TBL] [Abstract][Full Text] [Related]
50. Oximinoarylsulfonamides as potent HIV protease inhibitors.
Yeung CM; Klein LL; Flentge CA; Randolph JT; Zhao C; Sun M; Dekhtyar T; Stoll VS; Kempf DJ
Bioorg Med Chem Lett; 2005 May; 15(9):2275-8. PubMed ID: 15837308
[TBL] [Abstract][Full Text] [Related]
51. Theoretical analysis of secondary structures of beta-peptides.
Wu YD; Han W; Wang DP; Gao Y; Zhao YL
Acc Chem Res; 2008 Oct; 41(10):1418-27. PubMed ID: 18828608
[TBL] [Abstract][Full Text] [Related]
52. Structure-guided design of C2-symmetric HIV-1 protease inhibitors based on a pyrrolidine scaffold.
Blum A; Böttcher J; Heine A; Klebe G; Diederich WE
J Med Chem; 2008 Apr; 51(7):2078-87. PubMed ID: 18348517
[TBL] [Abstract][Full Text] [Related]
53. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
Mizutani MY; Itai A
J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
[TBL] [Abstract][Full Text] [Related]
54. Automated docking of highly flexible ligands by genetic algorithms: a critical assessment.
Cecchini M; Kolb P; Majeux N; Caflisch A
J Comput Chem; 2004 Feb; 25(3):412-22. PubMed ID: 14696075
[TBL] [Abstract][Full Text] [Related]
55. Exploring experimental sources of multiple protein conformations in structure-based drug design.
Damm KL; Carlson HA
J Am Chem Soc; 2007 Jul; 129(26):8225-35. PubMed ID: 17555316
[TBL] [Abstract][Full Text] [Related]
56. Design, synthesis, evaluation, and crystallographic-based structural studies of HIV-1 protease inhibitors with reduced response to the V82A mutation.
Clemente JC; Robbins A; Graña P; Paleo MR; Correa JF; Villaverde MC; Sardina FJ; Govindasamy L; Agbandje-McKenna M; McKenna R; Dunn BM; Sussman F
J Med Chem; 2008 Feb; 51(4):852-60. PubMed ID: 18215016
[TBL] [Abstract][Full Text] [Related]
57. Protein flexibility in ligand docking and virtual screening to protein kinases.
Cavasotto CN; Abagyan RA
J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
[TBL] [Abstract][Full Text] [Related]
58. A knowledge-based structure-discriminating function that requires only main-chain atom coordinates.
Makino Y; Itoh N
BMC Struct Biol; 2008 Oct; 8():46. PubMed ID: 18957132
[TBL] [Abstract][Full Text] [Related]
59. Docking unbound proteins with MIAX: a novel algorithm for protein-protein soft docking.
Del Carpio Munoz CA; Peissker T; Yoshimori A; Ichiishi E
Genome Inform; 2003; 14():238-49. PubMed ID: 15706538
[TBL] [Abstract][Full Text] [Related]
60. Structure, dynamics and solvation of HIV-1 protease/saquinavir complex in aqueous solution and their contributions to drug resistance: molecular dynamic simulations.
Wittayanarakul K; Aruksakunwong O; Sompornpisut P; Sanghiran-Lee V; Parasuk V; Pinitglang S; Hannongbua S
J Chem Inf Model; 2005; 45(2):300-8. PubMed ID: 15807491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
